Navigation Links
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
Date:5/8/2008

CTOR(R) Patch results in minimal systemic absorption of diclofenac, one of the best selling and most widely used orally administered NSAIDs worldwide."

Acute pain is a common problem, with one in four adult Americans suffering an episode of pain lasting longer than 24 hours.(1)

Efficacy and Tolerability of FLECTOR(R) Patch in the Treatment of Minor Soft Tissue Injury Pain (Abstract #8332/Poster #278)(2)

The efficacy and tolerability of FLECTOR(R) Patch was evaluated in a randomized, double-blind, placebo-controlled, parallel-group trial of 418 patients, aged 18-65 years who rated the minor soft tissue injuries they sustained within seven days of study entry as having a pain intensity of greater than or equal to five on a zero to 10 scale. Patients self-administered FLECTOR(R) Patch every 12 hours to the injury site. The primary study outcome was post-treatment pain, expressed as a proportion of the baseline pain score, which was recorded on a visual analog scale of zero to 10 in a diary, twice-daily for 14 days, or until pain resolution. The secondary study outcomes included end-of-treatment Investigator Global Assessment of Response to Therapy (a five-point scale, "none" to "excellent"), and time to pain resolution (four scores less than or equal to two).

Patients treated with FLECTOR(R) Patch experienced improved mean pain scores (40.4 percent of baseline score) versus patients using placebo patch (47.4 percent, p<0.05); overall pain reduction was 14.8 percent. FLECTOR(R) Patch patients also reached pain resolution three days sooner than those in the placebo patch group (median, 10.0 versus 13.5 days, p=0.01). Additionally, at the conclusion of the study, the Investigator Global Assessment of Response to Therapy significantly favored the FLECTOR(R) Patch: patient response to treatment was rated "good" to "excellent" for 57.8 percent of FLECTOR(R) Patch patients, versus 48.4 percent of placebo patch patients, and a "no"/"poor" response w
'/>"/>

SOURCE Alpharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
2. Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology
3. Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
4. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
5. Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections
6. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
7. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
8. Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
9. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- MedSolutions ( www.medsolutions.com ), a leading provider ... new studies highlighting the dangers of excess radiation ... tests. ,, "When used properly, CT imaging ... Gregg Allen, M.D., chief medical officer of MedSolutions. ... that stricter quality control measures are necessary to ...
(Date:12/16/2009)... -- HDT Engineered Technologies (HDT), a leader in ... principal subcontractor for the mechanical development of the ... anthropromorphic arm technology that will give patients improved, ... including a sense of touch. ,, As ... (DARPA) Revolutionizing Prosthetics 2009 (RP2009) project, the MPL ...
(Date:12/16/2009)... Ethicon, Inc., a Johnson & Johnson ... worldwide leader in surgical care, and Acclarent, Inc., ... designing, developing and commercializing devices that address conditions ... announced a definitive merger agreement whereby Ethicon will ... $785 million net of estimated cash on hand ...
Breaking Medicine Technology:MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 2MedSolutions Applauds Renewed Focus on the Dangers of Radiation Exposure 3HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4Availity Provides Real Time Access to WellCare 55281 1Availity Provides Real Time Access to WellCare 55281 2Aging Science Leaders to Gather During Active Aging Week to Encourage Discovery in Healthy Living and Longevity 55277 1Aging Science Leaders to Gather During Active Aging Week to Encourage Discovery in Healthy Living and Longevity 55277 2Aging Science Leaders to Gather During Active Aging Week to Encourage Discovery in Healthy Living and Longevity 55277 3Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 1Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 2Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 3Just in Time for Allergy Season ZYRTEC 28R 29 Provides New Solutions for Adults and Children 55272 4
... Studies TAX 323 and TAX 324 Published, ... results of two clinical studies demonstrating that,Taxotere(R) (docetaxel) ... for induction therapy, significantly improved overall,survival (OS) in ... head and neck (SCCHN) are published in the ...
... sleep apnea and sleep behavior,disorders, ROCHESTER, Minn., ... diagnosing and treating patients with a,variety of sleep ... at CHEST 2007, the annual meeting of the ... 20-25. The following are,brief summaries of select presentations., ...
Other Medicine Technology:Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 2Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 3Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 4Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 5Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 7Mayo Clinic Physicians Report Findings from Research on Sleep Disorders 2Mayo Clinic Physicians Report Findings from Research on Sleep Disorders 3Mayo Clinic Physicians Report Findings from Research on Sleep Disorders 4
(Date:12/17/2009)... Nathan law firm, litigators of complex personal injury and insurance cases, ... ... Tulsa, OK (Lexis Nexis) December 17, 2009 -- ... years of experience handling personal injury and insurance coverage disputes, has ... top attorneys in the state of Oklahoma for 2009-2010., , ,Only ...
(Date:12/17/2009)... Children’s Hospital from nearby hot tub company helps raise money ... ... Salt Lake City, UT (PRWEB) December ... the donation of a Bullfrog Spa to aid in fund ... City, Utah. Primary Children’s Medical Center, serving child patients from ...
(Date:12/16/2009)... sector revenue increased by 5.7 percent in 2008 ... 2007, according to new data from the U.S. ... North American Industry Classification System as NAICS 62. ... come from the 2008 Service Annual Survey: ... of tables which provides estimates of revenue, sources ...
(Date:12/16/2009)... -- Smart Balance, Inc. (Nasdaq: SMBL ) announced ... two-year stock repurchase program of up to $25 million, ... the confidence we have in the prospects of our ... for all of our shareholders, while at the same ... Smart Balance, Inc. Chairman and Chief Executive Officer. ,, ...
(Date:12/16/2009)... 16 New Enterprise Associates, Inc. (NEA), ... that one of its portfolio companies, Acclarent, Inc., ... acquired by Ethicon, Inc., a Johnson & Johnson ... million (net of estimated cash on hand at ... to designing, developing and commercializing devices that address ...
Breaking Medicine News(10 mins):Health News:Jody Nathan, Highly Regarded Tulsa Attorney, Named to 2009 Oklahoma Super Lawyers List 2Health News:Bullfrog Spas Helps Critically Ill Children 2Health News:Bullfrog Spas Helps Critically Ill Children 3Health News:Bullfrog Spas Helps Critically Ill Children 4Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 2Health News:Census Bureau: Health Care Industries Showed Modest Growth in Revenue in 2008 3Health News:Smart Balance Authorizes Stock Repurchase Program 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3
... outbreak of measles in a village in the northern state ... further 100 children to be hospitalised. ,"The epidemic ... two hospitals at Maiduguri, the state capital, for treatment," Abdulrahman ... ministry told AFP. ,He said Jimkilo village, where ...
... for the nearest beer bar or liquor outlet to quench their ... is evident from the taverns in star-rated hotels in Jaipur which ... prefer beer with a mere ten percent opting for hard liquor. ... well as stimulating effects in sultry climate. ,"It is ...
... a soccer ball-shaped nano-particle called buckyball has been identified. ... has the ability to block allergic reaction, making the ... disease is the sixth leading cause of chronic disease ... been developed to control allergy, no cure has been ...
... pollutants do their job and then to make them ... conducted on those bacteria by cornell researchers using computer ... Ithaca sewage sludge in 1997 by James Gossett, Cornell ... studied by Stephen Zinder, Cornell professor of microbiology, are ...
... jail time if teenage children drink alcohol at parties, even at ... at their home for their 16-year-old's birthday party to stop him ... alcohol for under 21s, and were sent to jail for two ... states allow for fines of up to 1,000 dollars for each ...
... a Jewish prostitute might have led Hitler to orchestrate ... psychiatrists. ,Hitler might have contracted syphilis, which, ... of the Jews and the mentally retarded. ... to psychiatrist Dr Bassem Habeeb. ,Dr Habeeb ...
Other Medicine News:Health News:Buckyball Has the Ability to Fight Against Allergy: Research 2Health News:Insilico Studies on Chlorine Eating Bacteria 2Health News:US Parents Risk Jail When Their Teens Drink at Parties 2Health News:Hitler's Holocaust may Have Stemmed from Syphilis from Jewish Prostitute 2
Lyophilized, tri-level assayed human serum-based control, Low, intermediate and high levels, Lot-specific target values provided, Suitable for use with RIA, EIA and chemiluminescent,methodo...
The assay is an immunometric ('sandwich') EIA for the quantitative measurement of LH in human serum or plasma. LH in the sample is bound by 2 monoclonal anti-LH antibodies directed at different epito...
... Follicle-stimulating hormone (FSH) is a ... pituitary gland. Like hCG, LH and ... a noncovalently-linked dimer consisting of alpha- ... are stimulated by gonadotropin-releasing hormone (GnRH) ...
... Class II Direct to High Res SSP kits provide ... single tray. Locus specific typing on a single tray ... Straight from genomic DNA to high resolution results, ... level typing with a single tray , Unique reaction ...
Medicine Products: